CLINICAL_TRIALS
trial_result
· 2023-12-19
Clinical Trial Update: Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD [Phase 2]
Summary
Phase 2 trial update for Humacyte’s human acellular vessel (HAV) used in femoro-popliteal bypass for peripheral artery disease; the study has completed and resu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Humacyte, Inc. | Conditions: Peripheral Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-12-19